3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
13
Myelodysplastic Syndromes
5
Advanced Solid Tumors
5
Advanced Solid Tumour
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Solid Tumor
2
Advanced Lung Cancer
2
Unresectable Locally Recurrent Breast Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Non-small Lung Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Sclerosis
1
Metastatic Solid Tumors
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Digestive System Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Interventions
Oxaliplatin
10
Leucovorin
9
Fluorouracil
9
Specimen Handling
6
Cetuximab
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
cemiplimab
3
Pemetrexed
3
fludarabine
2
dehydroftorafur
2
aldesleukin
2
Surveys and Questionnaires
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipiracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Injections
×
30 days
×
Clear all
No trials found.